glp-1 medications in the workplace Navigate Long-term Success of GLP-1s Hinges

Historically, no, but qualifying Medicare beneficiaries can get coverage for Wegovy from July 1, 2026, until December 31, 2027, via the new Medicare GLP-1 Bridge program

This scenario applies more often in advanced type 2 diabetes where HbA1c targets remain unmet despite optimized single-agent dosing

The letter authors urged clinicians to be aware of the adverse effects of drugs like Ozempic on the small intestine

Beyond Type 1 is hopeful the new drug will be widely covered by all insurance plans that currently cover injectable glucagon

Anguo Wu, Email: [email protected]

But Eimer emphasized that the findings should not discourage appropriate use of GLP-1 drugs, which have become increasingly popular for treating diabetes, obesity, cardiovascular disease and sleep apnea